Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 62584-23-0 | MDL No. : | MFCD04115832 |
Formula : | C8H5ClF3NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PIYDLRBTABXQSP-UHFFFAOYSA-N |
M.W : | 223.58 | Pubchem ID : | 3770849 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.12 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 44.55 |
TPSA : | 43.09 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.51 cm/s |
Log Po/w (iLOGP) : | 1.46 |
Log Po/w (XLOGP3) : | 3.03 |
Log Po/w (WLOGP) : | 3.61 |
Log Po/w (MLOGP) : | 2.83 |
Log Po/w (SILICOS-IT) : | 2.67 |
Consensus Log Po/w : | 2.72 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -3.32 |
Solubility : | 0.107 mg/ml ; 0.000478 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.6 |
Solubility : | 0.0561 mg/ml ; 0.000251 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.5 |
Solubility : | 0.0712 mg/ml ; 0.000318 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.46 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
In dichloromethane; at 40.0℃; | General procedure: Oxalyl chloride (6.61mmol) was added dropwise into a stirred solution of the appropriate benzamide (2.6mmol) in CH2Cl2 (10mL). The mixtures were heated at reflux for 20-22h. Then, solvents were evaporated in vacuo to give the respective crude benzoyl isocyanates 4a-k, which were used immediately in the next step without purification. Aminoindolin-2-one (2.8mmol) was added into a stirred solution of the appropriate benzoyl isocyanate (2.8mmol) in acetonitrile (10mL). After addition, each mixture was heated at 70-80C for 2-3h. The solid products were each filtered, washed with acetonitrile, and air dried. |
[ 34328-46-6 ]
4-Chloro-3-(trifluoromethyl)benzaldehyde
Similarity: 0.81
[ 771583-81-4 ]
4-Chloro-2-(trifluoromethyl)benzylamine
Similarity: 0.77
[ 39226-96-5 ]
(2-Chloro-3-(trifluoromethyl)phenyl)methanamine
Similarity: 0.76
[ 34328-46-6 ]
4-Chloro-3-(trifluoromethyl)benzaldehyde
Similarity: 0.81
[ 771583-81-4 ]
4-Chloro-2-(trifluoromethyl)benzylamine
Similarity: 0.77
[ 39226-96-5 ]
(2-Chloro-3-(trifluoromethyl)phenyl)methanamine
Similarity: 0.76
[ 34328-46-6 ]
4-Chloro-3-(trifluoromethyl)benzaldehyde
Similarity: 0.81
[ 771583-81-4 ]
4-Chloro-2-(trifluoromethyl)benzylamine
Similarity: 0.77
[ 39226-96-5 ]
(2-Chloro-3-(trifluoromethyl)phenyl)methanamine
Similarity: 0.76
[ 771583-81-4 ]
4-Chloro-2-(trifluoromethyl)benzylamine
Similarity: 0.77
[ 39226-96-5 ]
(2-Chloro-3-(trifluoromethyl)phenyl)methanamine
Similarity: 0.76
[ 34328-46-6 ]
4-Chloro-3-(trifluoromethyl)benzaldehyde
Similarity: 0.81
[ 771583-81-4 ]
4-Chloro-2-(trifluoromethyl)benzylamine
Similarity: 0.77
[ 39226-96-5 ]
(2-Chloro-3-(trifluoromethyl)phenyl)methanamine
Similarity: 0.76